Investigating how diet and gut health affect liver disease and Alzheimer's risk in diverse populations
Official title: Longitudinal Study of Early NAFLD Progression and the Gut Microbiome in Asian Americans, Native Hawaiians and Whites
Funded at University of Hawaii at Manoa · NIH-10940527 · Data updated 2026-11-12
This study is looking at how the gut bacteria and diet affect the early stages of non-alcoholic fatty liver disease and liver damage over ten years, especially in people from different backgrounds, to find new ways to prevent and treat these conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Hawaii at Manoa NIH-funded |
| Lab location | 1 site (Honolulu, United States) |
| Project start | September 26, 2022 |
| Project end | June 30, 2027 |
| Funding year | 2024 |
| Award (this year) | $401,212 |
| NIH project number | 3R01MD018265-03S1 |
| Project ID | NIH-10940527 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals from Asian American, Native Hawaiian, and White backgrounds who are at risk for NAFLD or Alzheimer's disease.
✕Less likely to help
Patients who do not belong to the specified racial or ethnic groups or those without risk factors for NAFLD or Alzheimer's disease may not benefit from this research.
What this research studies
This research examines the early progression of non-alcoholic fatty liver disease (NAFLD) and liver fibrosis over a decade, focusing on how the gut microbiome influences these conditions in relation to diet. It specifically looks at participants from diverse racial and ethnic backgrounds, including Asian Americans, Native Hawaiians, and Whites, to understand their varying susceptibilities to NAFLD and Alzheimer's disease. By analyzing data from a large cohort, the study aims to uncover new risk factors and relationships that could lead to better prevention and treatment strategies for these diseases.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and management of liver disease and Alzheimer's risk, particularly for diverse populations.
How similar studies have gone: Previous research has indicated significant differences in Alzheimer's risk among various racial and ethnic groups, suggesting that this approach could yield valuable insights.
Where this research is happening
-
University of Hawaii at Manoa
Honolulu, United States Active
Researchers
- Principal investigator: Lim, Unhee — University of Hawaii at Manoa
- Study coordinator: Lim, Unhee
Related research
Other NIH-funded projects on the same topics.
-
Long-term study of NAFLD progression and gut bacteria in diverse groups
We’re following people over time to see how the gut microbiome and diet relate to fatty liver disease progression in diverse racial/ethnic groups.
-
Long-term gut microbiome and NAFLD progression in diverse adults
A long-term study will follow 300 adults from diverse racial groups to see how their gut bacteria relate to the progression of fatty liver disease over about a decade.
-
Understanding Liver Disease Progression and Gut Health in Diverse Communities
This research looks at how changes in gut bacteria might be connected to the progression of non-alcoholic fatty liver disease (NAFLD) over time in Asian Americans, Native Hawaiians, and White individuals.
-
Understanding Liver Fat and Gut Health in Diverse Communities
This project looks at how gut bacteria and diet might be connected to the progression of fatty liver disease in Asian Americans, Native Hawaiians, and White individuals.
-
Investigating how gut bacteria affect liver disease progression in diverse populations
This study is looking at how the bacteria in our gut and what we eat might affect the worsening of non-alcoholic fatty liver disease (NAFLD) over time in Asian Americans, Native Hawaiians, and Whites, and it involves tracking participants for almost ten years to learn more about these connections.
-
Multi-agent AI to annotate enzymes in the human gut microbiome
A team at a major university will build an AI system that automatically curates and labels the functions of enzymes in the human gut microbiome to speed up understanding their health effects.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.